From lifelong therapy to intermittent treatment: the future of chronic myeloid leukemia management—commentary on interim results from DAstop2 trial
@article{ACTR10217,
author = {Tomáš Horňák and Daniela Žáčková},
title = {From lifelong therapy to intermittent treatment: the future of chronic myeloid leukemia management—commentary on interim results from DAstop2 trial},
journal = {AME Clinical Trials Review},
volume = {2},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10217}
}